|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5580 USD | +2.67% |
|
-6.86% | -49.27% |
| 06-10 | OneMedNet Says 2026 New Bookings Exceed $3 Million | MT |
| 05-15 | OneMedNet Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
Revenues | 1.09M | 1.15M | 1.02M | 643K | 1.36M | |
Total Revenues | 1.09M | 1.15M | 1.02M | 643K | 1.36M | |
Cost of Goods Sold, Total | 1.21M | 1.51M | 1.15M | 924K | 1.86M | |
Gross Profit | -113K | -361K | -128K | -281K | -503K | |
Selling General & Admin Expenses, Total | 1.95M | 4.8M | 6.61M | 7.86M | 7.65M | |
R&D Expenses | 643K | 953K | 1.63M | 1.47M | 1.52M | |
Other Operating Expenses, Total | 2.6M | 5.76M | 8.25M | 9.32M | 9.16M | |
Operating Income | -2.71M | -6.12M | -8.37M | -9.6M | -9.67M | |
Interest Expense, Total | -195K | -403K | -749K | -147K | -67K | |
Interest And Investment Income | - | - | - | - | - | |
Net Interest Expenses | -195K | -403K | -749K | -147K | -67K | |
Other Non Operating Income (Expenses) | -34.9K | -46.82K | -3.58M | -375K | 1.41M | |
EBT, Excl. Unusual Items | -2.94M | -6.57M | -12.7M | -10.13M | -8.33M | |
Asset Writedown | - | - | -10.5M | - | - | |
Other Unusual Items | - | - | - | - | 5.53M | |
EBT, Incl. Unusual Items | -2.94M | -6.57M | -23.21M | -10.13M | -2.8M | |
Income Tax Expense | - | - | - | 2K | 1K | |
Earnings From Continuing Operations | -2.94M | -6.57M | -23.21M | -10.13M | -2.8M | |
Net Income to Company | -2.94M | -6.57M | -23.21M | -10.13M | -2.8M | |
Net Income - (IS) | -2.94M | -6.57M | -23.21M | -10.13M | -2.8M | |
Net Income to Common Incl Extra Items | -2.94M | -6.57M | -23.21M | -10.13M | -2.8M | |
Net Income to Common Excl. Extra Items | -2.94M | -6.57M | -23.21M | -10.13M | -2.8M | |
Per Share Items | ||||||
Net EPS - Basic | -0.2 | -1.44 | -0.98 | -0.36 | -0.06 | |
Basic EPS - Continuing Operations | -0.2 | -1.44 | -0.98 | -0.36 | -0.06 | |
Basic Weighted Average Shares Outstanding | 14.96M | 4.56M | 23.57M | 28.08M | 44.55M | |
Net EPS - Diluted | -0.2 | -1.44 | -0.98 | -0.36 | -0.06 | |
Diluted EPS - Continuing Operations | -0.2 | -1.44 | -0.98 | -0.36 | -0.06 | |
Diluted Weighted Average Shares Outstanding | 14.96M | 4.56M | 23.57M | 28.08M | 44.55M | |
Normalized Basic EPS | -0.12 | -0.9 | -0.34 | -0.23 | -0.12 | |
Normalized Diluted EPS | -0.12 | -0.9 | -0.34 | -0.23 | -0.12 | |
Supplemental Items | ||||||
EBITDA | -2.7M | -6.09M | -8.35M | -9.55M | -9.6M | |
EBITA | -2.71M | -6.12M | -8.37M | -9.6M | -9.67M | |
EBIT | -2.71M | -6.12M | -8.37M | -9.6M | -9.67M | |
Total Revenues (As Reported) | - | - | - | 643K | 1.36M | |
Effective Tax Rate - (Ratio) | - | - | - | -0.02 | -0.04 | |
Normalized Net Income | -1.84M | -4.1M | -7.94M | -6.33M | -5.2M | |
Supplemental Operating Expense Items | ||||||
Selling and Marketing Expenses | 605K | 958K | 1.11M | 830K | 1.27M | |
General and Administrative Expenses | 1.2M | 3.45M | 5.27M | 7.03M | 6.38M | |
Research And Development Expense From Footnotes | 643K | 953K | 1.63M | 1.47M | 1.52M | |
Stock-Based Comp., COGS (Total) | - | - | - | - | 55K | |
Stock-Based Comp., R&D Exp. (Total) | - | - | - | - | 115K | |
Stock-Based Comp., S&M Exp. (Total) | - | - | - | - | 75K | |
Stock-Based Comp., G&A Exp. (Total) | - | 1.59M | - | - | 1.79M | |
Stock-Based Comp., Other (Total) | 97.87K | 7.71K | - | 14.68M | - | |
Total Stock-Based Compensation | 97.87K | 1.6M | - | 14.68M | 2.03M |
- Stock Market
- Stocks
- ONMD Stock
- Financials OneMedNet Corporation
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
